இங்கோ சக்ரவர்த்தி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இங்கோ சக்ரவர்த்தி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இங்கோ சக்ரவர்த்தி Today - Breaking & Trending Today

Thermo Fisher completes $450M acquisition of San Diego COVID test maker Mesa Biotech


Print
Mesa Biotech, a privately held San Diego company that developed one of the first rapid COVID-19 diagnostic tests to get regulatory approval, has been acquired by life sciences giant Thermo Fisher Scientific for $450 million in cash.
The deal, first announced in January, closed this week. Based in Waltham, Mass., Thermo Fisher could wind up paying up to $100 million more for Mesa if the company hits certain milestones.
In March, Mesa received emergency use authorization from the U.S. Food and Drug Administration for its Accula molecular COVID-19 test system. It uses a desktop PCR analyzer device and a compact, single-use cartridge to detect the coronavirus in 30 minutes. ....

Los Alamos , United States , San Diego , Mesa Accula , Mark Stevenson , Ingo Chakravarty , National Institutes Of Health , Drug Administration , Thermo Fisher , Los Alamos National Lab , Mesa Biotech , Thermo Fisher Scientific , National Institutes , லாஸ் அலமோஸ் , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , குறி ஸ்டீவன்சன் , இங்கோ சக்ரவர்த்தி , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , தெர்மோ மீனவர் , லாஸ் அலமோஸ் தேசிய ஆய்வகம் , மீசா பயோடெக் , தெர்மோ மீனவர் அறிவியல் , தேசிய நிறுவனங்கள் ,

Thermo Fisher Scientific to acquire point-of-care molecular


Industry News: Thermo Fisher Scientific to acquire point-of-care molecular diagnostics provider Mesa Biotech
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
22 Jan 2021
Thermo Fisher Scientific Inc., a world leader in serving science, has announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction.
Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Mesa Biotech s patented technology expands the availability o ....

United States , San Diego , Mark Stevenson , Ingo Chakravarty , Thermo Fisher Scientific Inc , Clinical Laboratory Improvements Amendments , Drug Administration , Thermo Fisher , Thermo Fisher Life Sciences Solutions Segment , Mesa Biotech Inc , Industry News , Thermo Fisher Scientific , Fisher Scientific Inc , Mesa Biotech , Accula System , Emergency Use Authorization , Life Sciences Solutions , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , குறி ஸ்டீவன்சன் , இங்கோ சக்ரவர்த்தி , தெர்மோ மீனவர் அறிவியல் இன்க் , மருத்துவ ஆய்வகம் மேம்பாடுகள் திருத்தங்கள் , தெர்மோ மீனவர் , தெர்மோ மீனவர் வாழ்க்கை அறிவியல் தீர்வுகள் பிரிவு , மீசா பயோடெக் இன்க் ,

Thermo Fisher Scientific to acquire Mesa Biotech for up to $550M


Print
Thermo Fisher Scientific plans to acquire point-of-care molecular diagnostics firm Mesa Biotech for up to $550 million, the company said on Tuesday.
Under the terms of a definitive agreement, Thermo Fisher will pay approximately $450 million in cash and up to an additional $100 million in cash if certain milestones are met after the acquisition.
The deal is expected to close in the first quarter. Following the acquisition, Mesa Biotech will become part of Thermo Fisher s Life Sciences Solutions business segment.
Mesa Biotech, which is based in San Diego, has approximately 500 employees and sells a PCR-based rapid point-of-care platform for infectious disease diagnostics, including tests for COVID, influenza A and B, respiratory syncytial virus, and Strep A. In 2020, the company had approximately $45 million in revenue. ....

San Diego , United States , Mark Stevenson , Ingo Chakravarty , Biomedical Advances Research , Drug Administration , Thermo Fisher Life Sciences Solutions , Development Authority , Thermo Fisher , Thermo Fisher Scientific , Mesa Biotech , Life Sciences Solutions , Advances Research , Fisher Executive , Chief Operating Officer Mark Stevenson , Mesa Biotech President , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , குறி ஸ்டீவன்சன் , இங்கோ சக்ரவர்த்தி , தெர்மோ மீனவர் வாழ்க்கை அறிவியல் தீர்வுகள் , வளர்ச்சி அதிகாரம் , தெர்மோ மீனவர் , தெர்மோ மீனவர் அறிவியல் , மீசா பயோடெக் , வாழ்க்கை அறிவியல் தீர்வுகள் ,